RNS Number : 4418T
Spectra Systems Corporation
20 March 2023
 

 Spectra Systems Corporation

 

Audited results for the twelve months ended 31 December 2022

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Spectra Systems Corporation (the "Company"), a leader in machine-readable high speed banknote authentication, brand protection technologies, and gaming security software, is pleased to announce its results for the twelve months ended 31 December 2022.

 

 

Financial highlights:

 

·      Revenue of $19,627k (2021: $16,592k) up 18%

 

·      Adjusted EBITDA1 up 17% at $8,077k (2021: $6,896k)

 

·      Adjusted PBTA1 up 17% to $7,765k (2021: 6,622k)

 

·      Adjusted earnings2 per share up 21% to US 14.5 cents (2021: US 12.0 cents)

 

·      Cash generated from operations of $8,040k (2021: $8,084k) 

 

·      The Board are declaring an increased annual dividend of US$0.115 per share to be paid in June 2023

 

·      Strong, debt-free balance sheet, with cash3 of $17,496k (2021: $16,775k) at 31 December

 

·      Buy-back of 500,000 shares during 2022 at a total cost of US$807k

 

1 Before stock compensation expense and excludes noncontrolling interest

2 Before amortization and stock compensation expense, excludes noncontrolling interest

3 Does not include $500,000 (2021: $1,099k) of restricted cash and investments

 

 

Operational highlights:

  

·     Continued momentum towards customer acceptance of latest pre-production sensor units.

·     Completed supply chain mitigation program with central bank worth $1.3mm for preparation and given go ahead for production in 2022 at 21% price increase.

 

·     Increased sales efforts for polymer substrates with appointment of Global Sales Director for Banknote Technology and launch of enhanced website.

 

·    Central bank request to provide large quantities of Fusion substrate for a large print trial ongoing in 2023.

 

·      Continued strong sales of K-cup optical materials through a second large customer.

 

·   Increased operational efficiency in software security group by launching a new tool to significantly improve our ability to manage customer support.

 

 

Commenting on the results, Nabil Lawandy, Chief Executive Officer, said:

 

Company's earnings and revenues are up substantially over 2021 both due to strong sales which would in themselves had enabled the company to exceed market expectations and which were further increased due to over-manufacturing of covert materials for a Central Bank. Improved financial planning has been put in place for 2023. Our cash position remains strong due to sensor development milestones and prepayments as well as additional sales in optical and covert materials.  In addition, information from one of our major licensees as well as improved visibility on current sensor life have allowed us to write-off inventory which we anticipate will not contribute to future sales.

Spectra Systems, with our proven track record of developing solutions for our customers in record time, has capitalized on the environment that was created by the Covid-19 pandemic.  We have successfully completed a supply chain mitigation program with a central bank customer by manufacturing in-house a previously commercially sourced chemical.  This effort has resulted in payment for the development as well as an approval to manufacture material starting in Q4 of 2022 at a higher price.

On the materials front, our revenue from K-cup printers continues to be strong and we began testing with a third printer in Canada in 2022. Taggant material orders from a central bank customer were again at high levels, further bolstering consumable revenue.

"The Board therefore believes that the Company is on track to achieve record earnings and meet market expectations for 2023."

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

                         

Tel: +1 (0)401 274 4700

 

WH Ireland Limited (Nominated Adviser and Joint Broker)

Chris Fielding/James Bavister/Andrew de Andrade (Corporate Finance)

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 7220 1650

 

 

Tel: +44 (0)20 3328 5665

 

 


The person responsible for arranging the release of this announcement on behalf of the Company is Dr. Nabil Lawandy, Chief Executive Officer of the Company.

 

 

Chief Executive Officer's statement

 

Introduction

We are delighted to report that we significantly outperformed the 2021 results while our year end cash position is the highest in the Company's history.

Revenue for the year was up 18% at $19,627k (2021: $16,592k), primarily driven by pre-production development contracts as well as ongoing demand for our materials to meet production for our long-standing central bank customer.

 

The adjusted EBITDA (before stock compensation expense) for the year increased 17%, to $8,077k compared to the prior year of $6,896k.  

 

Having generated cash from operations of $8,040k (2021: $8,084k), cash at the period end was $17,496k (2021: $16,775k), excluding $500,000 of restricted cash and investments (2021: $1,099k). This is notwithstanding $5,004k paid to shareholders during June in the form of the Company's dividend of $0.11 per share and $807k used for buying back 500,000 shares. 

 

 

Review of Operations

 

 

Physical and Software Authentication Business

 

The Authentication Systems business generated revenue of $18,164k (2021: $14,718k) and Adjusted EBITDA of $8,005k (2021: $6,556k). Authentication Systems revenues were driven by sales of covert materials and the funding of a new in-house capability and facility to combat supply chain issues relating to one of our central bank customers.  Authentication Systems revenue was further increased by milestone payments which are part of the sensor development program with one of our long-standing central bank customers. We continue to advance through the acceptance process with this central bank with the delivery of preproduction units of our latest sensor in late 2024. In addition, revenue from optical and security phosphour materials remained strong while licence payments from our licensee continued with on time payments and at the contracted value.

 

Through our vertically integrated manufacturing we have been able to produce high quality conducting and opacified polymer substrate for evaluation by central banks, ink suppliers and printing organizations.  We have produced a large number of print ready sheets for a Middle Eastern central bank print trial which has resulted in an additional large scale print trial scheduled for Q2 2023. The Company has formed a close working relationship with the largest commercial printer of polymer banknotes and is developing a house note which will incorporate both our FusionTM machine readable security as well as their newest public security feature. The objective of this joint development will produce polymer banknotes of the highest quality for a joint marketing effort. 

 

We are increasing our sales and marketing efforts for FusionTM as well as our full suite of banknote products having introduced Fusion at the Banknote Conference and appointed a UK based Global Director of Sales for Banknote Technology.

 

With the TruBrandTM authentication product having been successfully introduced into the Chinese tobacco market in 2019 annually and for use in stationary products in 2021, we have completed two successful gravure tests with another large supplier of cigarettes in China and plan to additional print tests in Q1 of 2023 with two additional tobacco companies in China. We continue to expand our search for new TruBrandTM customers outside of China, including with a major Japanese printer and a partnership with a company in India bidding on authentication of both dairy products, as well as transit certificates, and with our multinational Fusion polymer partner for labels.  We have also developed smartphone readable security threads to further expand the palette of target applications and potential partners.  In addition, we continue to work with a printer for a well-respected French luxury brand to help protect their products sold in China using authentication technology we acquired several years ago.

 

Our K-cup materials business has grown significantly after a new customer began purchasing our products during 2021. In 2022, we began a new testing program with a Canada based K-cup lid printer which we expect will produce revenues in Q2 2023.

 

On the software security side of the Company's business, the Secure Transactions Group generated an Adjusted EBITDA of $72k (2021: $340k) on revenue of $1,463k (2021: $1,874k).  The 2022 results are in line with expectations as we continue development of a new software platform. While this development

continues, we are focusing on the online lottery sector which grew during the pandemic through a partnership with NextGen Lotteries.

 

Finally, the Company has received several additional patents on authentication technology in Africa, China, and EU which protects our position in covert authentication as well as polymer substrates technology and machine readability

 

 

 

Banknote Cleaning and Disinfection Business

 

We have sold our first Banknote Disinfection System (BDS) for use by an Asian central bank.  The unit will be installed in the Q1 2023 and the terms included a 30% up-front payment as well as a follow-on service agreement.  As this system is scalable from 250,000 notes to over five million notes in a single cycle of one hour, we have the ability to accommodate a large spread of potential customer requirements.  With this first unit sold, we are ramping up our sales and marketing process to other central banks as well as the casino industry.  We do not expect this product to significantly contribute to revenue until another Covid outbreak or the emergence of another rapidly spreading pathogen.

 

 

Solaris BioSciences Investment Asset

 

In December 2020, the Company made an investment in Solaris BioSciences, whose results are consolidated by the Company. The technology is entirely optical and has evolved rapidly over the last months of 2022 and Q1 2023.  The technology is now capable of point of care measurement of plasma viscosity, cancer markers, lipid content, and LDL in microliters of blood. During H1 2022, Solaris BioSciences Holdings was formed as a UK company and has obtained EIS status with HMRC to expand the base of investment opportunities to the UK.

 

Corporate Governance

Spectra Systems is an AIM listed company and has always worked to abide by best practices as advised by both our bankers as well as our shareholders.  Recently ISS has issued certain recommendations regarding board composition, committee assignments, and option grants.

Our board has comprised the same Directors since our listing except for the addition of Mr. Jeremy Fry (UK based) who replaced Mr. Martin Jaskel after his untimely passing away.  In order to add a new dimension to the board, Dr. Barbara Paldus joined the board in H2 2022 as an Independent Non-Executive Director. She has extensive entrepreneurial experience, particularly in technology solutions, which will be of immense value to Spectra.

With the addition of this new board member, Dr. Nabil Lawandy exited the Audit Committee assignment as there is now a suitable replacement to share the burden of committee assignments.

With regards to Director option grants, the Company has adopted a new policy which will allow new Directors to receive a one-time option grant upon joining the board of directors.  Going forward, no Directors will be issued new options beyond the ones received at joining the board.  This is a compromise position relative to USA standards and UK guidance that Non-Executive Directors hold no options.

 

 

 

Strategy

The Company's strategy for increasing revenue and earnings continues to be focused on selling more products to existing customers as well as opening new sales channels for the full spectrum of our product offering.  We have had very good success in upselling existing central bank customers and commercially exploiting supply chain and pandemic related issues as part of our strategy.  Examples of these successes are the expansion of sensor capabilities for exotic counterfeits, the development and first sale of a banknote disinfection machine, and the commencement of a program with our customer to deal with supply chain issues now and going forward.

Our strategy for growing our newest and potentially transformative technology for polymer banknotes is based on validation, followed by commemorative banknote contract and then a full banknote denomination contract.  The validation is focused on three major stakeholders in the polymer banknote industry: the ink manufacturers, the commercial printers, and the state printworks.  Our primary targets are central banks which are currently using paper substrates and are contemplating a transition to polymer as well as central banks who have decided not to use polymer for higher denominations due to security concerns.

With regards to our optical materials and brand authentication products, we continue to propose to both central banks and overt security suppliers the concept of upgrading such features to incorporate public and machine-readable security. Our recent development of smartphone readable security threads will expand the opportunities of the technology to passports and secure documents.  The strategy behind this approach is based around partnering with current contract holders who can benefit from our technology and materials to upsell their existing customers. 

Finally, with our strong cash position, we do explore possible mergers and acquisitions which can immediately open doors to implement our upselling strategy, expand our customer base or strengthen our supply chain for Fusion polymer substrate. The exploration of such opportunities is now becoming more viable at larger scales as we expect to have even more significant cash resources through the successful delivery of the major central bank sensor contract.

 

Prospects

The Company continues to have a multitude of new short-term and long-term prospects. The short-term opportunities are expected in the 2023-2025 period and the long-term opportunities are expected in the 2025-2030-time frame. 

The near-term opportunities are:

Completion of sensor development and revenue recognition of development payments

New online Quality Control system contract

First sensor shipments to a central bank

TruBrandTM revenue reaching $1m per annum levels

Increased sales of our newest phosphour products

Expansion of our gaming software business in Canada and other non-USA customers and in the online lottery market

Opportunity to bid in a polymer banknote tender

A commemorative note series using our Fusion polymer substrate

 The longer-term opportunities are:

Supply of upgraded sensors worth up to $50MM in hardware to a central bank customer

Supply of FusionTM polymer substrate and sensors to a central bank for one or more banknote denominations

Further increase of covert authentication materials by a current or new central bank customer

The combination of these prospects, both short and long-term, has positioned the Company to continue its revenue and earnings growth over the coming years. We continue to develop cutting edge technologies to remain the technology leader in the authentication industry and to offer our shareholders growth through innovation for both new and existing customers.  

 

 

Dividend

With the Company having an eighth year of sustainable profits, reaching their highest levels since its admission to trading on AIM, and having sufficient resources to execute on its growth plans with its existing cash reserves, the Board is delighted to again issue an increased dividend. Our dividend policy takes account of the Group's profitability, underlying growth, and maintenance of sufficient cash reserves. The Board therefore intends to pay an annual dividend of US$0.115 per share on or about June 23, 2023 to shareholders of record as of June 5, 2023.

 

 

Nabil M. Lawandy

Chief Executive Officer

March 21, 2023 

 

 

                                   



Consolidated statements of income

for the years ended 31 December:

 

 

 

2022

 

 

2021

 

 

Audited

 

 

Audited

 

 

USD '000

 

 

USD '000

 

 

 

 

 

 

Revenue






   Product


$       11,208



$             9,281

   Service


           6,681



               5,524

   Licence and royalty


           1,738



               1,787

Total revenues


         19,627



             16,592







Cost of sales


           7,351



               6,069







   Gross profit


         12,276



             10,523







Operating expenses






   Research and development


           1,507



               1,399

   General and administrative


           3,023



               2,743

   Sales and marketing


              753



                  471

Total operating expenses


           5,283



               4,613







   Operating profit


           6,993



               5,910







Interest income


                17



                    40

Loss on sale of equipment


                --



                  (19)

Foreign currency income (loss)


                (8)



                   12







   Profit before taxes


           7,002



               5,943







Income tax expense


              901



                  878







   Net income


           6,101



               5,065







Net loss attributable to noncontrolling interest


              (46)



                  (98)







Net income attributable to Spectra Systems Corporation


$         6,147



 

$             5,163







Earnings per share






   Basic


$           0.14



$               0.11

   Diluted


$           0.13



$               0.11

 

All of the Group's operations are continuing

 



 

Consolidated statements of comprehensive income

for the years ended 31 December:

 

 


2022



2021

 


Audited



Audited

 


USD '000



USD '000

 






Net income


$         6,101



$         5,065

 






Other comprehensive income (loss)






Unrealized gain(loss) on currency exchange


              (45)



                10

 

Reclassification for realized (gain)loss in net income


                  8



              (12)

   Total other comprehensive loss


              (37)



                (2)







Comprehensive income


           6,064



           5,063







Net loss attributable to noncontrolling interest


              (46)



              (98)







Comprehensive income attributable to Spectra Systems Corporation


$         6,110



$         5,161







 

 



 

Consolidated balance sheets

as of 31 December:

 

 

 

2022

 

 

2021

 

 

Audited

 

 

Audited

 

 

USD '000

 

 

USD '000

Current assets






Cash and cash equivalents


$       17,496



$       16,775

Trade receivables, net of allowance


           3,677



           2,242

Unbilled and other receivables


           1,133



              630

Inventory


          1,599



           1,944

Prepaid expenses


              760



              298

   Total current assets


         24,665



         21,889

 






Non-current assets






Property, plant and equipment, net


           2,102



           1,439

Operating lease right of use assets, net


           1,217



              972

Intangible assets, net


           7,055



           7,161

Restricted cash and investments


              500



              500

Deferred tax assets


           1,881



           1,080

Other assets


              597



               111

   Total non-current assets


         13,352



         11,263

 






   Total assets


$       38,017



$       33,152







Current liabilities






Accounts payable


$            929



$            490

Accrued expenses and other liabilities


              504



              512

Operating lease liabilities, short term


              298



              286

Taxes payable


              684



              262

Deferred revenue


           4,626



           2,184

   Total current liabilities


           7,041



           3,734

 






Non-current liabilities






Operating lease liabilities, long term


              975



              739

Deferred revenue


           1,679



              758

   Total non-current liabilities


           2,654



           1,497

 






   Total liabilities


           9,695



           5,231







Stockholders' equity






Common stock


              450



              453

Additional paid in capital - common stock


         53,178



         53,833

Accumulated other comprehensive loss


            (174)



            (137)

Accumulated deficit


       (25,727)



       (26,870)

   Total Spectra Systems stockholders' equity


         27,727



         27,279

Noncontrolling interest


              595



              642







   Total liabilities and stockholders' equity


$       38,017



$       33,152

 

 



 

Statements of cash flows

for the year ended 31 December:

 

 

 

 

2022

 

 

2021

 

 

Audited

 

 

Audited

 

 

USD '000

 

 

USD '000

Cash flows from operating activities

 

 

 

 

 

Net income


$         6,101



$         5,065

Adjustments to reconcile net income to net cash provided by operating activities:






   Depreciation and amortization


              917



              831

   Stock based compensation expense


              142



                71

   Lease amortization expense


              287



              274

   Deferred taxes


            (801)



              320

   Allowance for doubtful accounts


                (4)



                   -

   Provision for excess and obsolete inventory


              694



              494

   Loss on sale of equipment


                   -



                19

   Changes in operating assets and liabilities






     Accounts receivables


         (1,428)



             346

     Unbilled and other receivables


            (503)



           (153)

     Inventory


            (349)



             356

     Prepaid expenses


            (463)



             (25)

     Other assets


            (500)



                   -

     Accounts payable


              441



             (44)

     Operating leases


            (285)



           (265)

     Accrued expenses and other liabilities


              417



               71

     Deferred revenue


           3,374



               72

Net cash provided by operating activities


           8,040



           8,084

 






Cash flows from investing activities






Restricted cash and investments


                   -



             599

Payment of patent and trademark costs


            (476)



           (471)

Proceeds from sale of equipment


                   -



            36 

Purchases of property, plant and equipment


            (988)



             (76)

Net cash provided (used) in investing activities


         (1,464)



               88

 






Cash flows from financing activities






Dividends paid


         (5,004)



        (4,302)

Repurchase of shares


            (807)



        (1,170)

Proceeds from exercise of stock options


                  6



              38

Net cash used in financing activities


         (5,805)



        (5,434)







Effect of exchange rate on cash and cash equivalents


              (50)



               (1)







Net increase in cash and cash equivalents


              721



           2,737

Cash and cash equivalents, beginning of year


         16,775



         14,038

Cash and cash equivalents, end of year


$       17,496



$       16,775

 

 

Notes to financial information

 

1. Basis of preparation

 

This report was approved by the Directors on the 16th day of March 2023.

 

This financial information has been prepared using the recognition and measurement principles of US Generally Accepted Accounting Principles. The Group has not elected to apply IAS 34 Interim Financial Reporting.

 

The principal accounting policies used in preparing the interim results are those the Company expects to apply in its financial statements for the year ending 31 December 2022 and are unchanged from those disclosed in the Company's Annual Report for the year ended 31 December 2021.

 

 

2. Earnings per share

 

The calculation of basic earnings per share is based on the net income divided by the weighted average number of common shares outstanding. Diluted earnings per share is calculated by considering the dilutive impact of common stock equivalents under the treasury stock method as if they were converted into common stock as of the beginning of the period or as of the date of grant, if later. Excluded from the calculation of diluted earnings per common share for the years ended 31 December 2022 and 2021 were 186,773 and 125,425 shares, respectively, related to stock options because their exercise prices would render them anti-dilutive. The following table shows the calculation of basic and diluted earnings per common share.


Full Year



Full Year


to 31 Dec 2022



to 31 Dec 2021

Numerator:





  Net income

$      6,147,374



$    5,162,830






Denominator:





  Weighted average common shares

      45,189,208



    45,353,550

     Effect of dilutive securities:





       Stock Options

        2,132,610



      2,385,480

  Diluted weighted average common shares

      47,321,818



    47,739,030






Earnings per common share:





   Basic:

$               0.14



$             0.11

   Diluted:

$               0.13



$             0.11

 

 

3. Copies of this statement are available to the public on the Company's website at http://www.spsy.com.

 

 

4. Nature of financial information

 

The Preliminary Announcement set out above is an extract from the forthcoming Annual Report and Accounts and does not represent statutory accounts for Spectra Systems Corporation. The statutory accounts of Spectra Systems Corporation in respect of the period ended 31 December 2022 will be delivered to the Registrars of Companies before the Company's Annual General Meeting.

 

It is anticipated that the Annual Report and Accounts will be circulated to shareholders of Spectra Systems Corporation by April 2023.

Appendix - Reconciliation of Non-GAAP measures

 

The Company publishes certain additional information in a non-statutory format in order to provide readers with an increased insight into the underlying performance of the business. Reconciliations to the GAAP measures are shown in the following tables:

 

 

 

2022

 

2021

 

 

USD '000

 

USD '000

 

Adjusted earnings before interest, taxes,

depreciation and amortization (EBITDA):

 

Operating profit


$            6,993


$            5,910

Depreciation


                 321


                 307

Amortization


                 594


                 524

Stock compensation


                 142


                  71

Operating loss - noncontrolling interest


                   46


                 101

Stock compensation - noncontrolling interest


                (19)


                 (17)

   Adjusted EBITDA


$            8,077


$            6,896

 

 

Adjusted profit before taxes and

amortization (PBTA):

 

Profit before taxes


$            7,002


$            5,943

Amortization


                 594


                 524

Stock compensation


                 142


                   71

Operating loss - noncontrolling interest


                   46


                 101

Stock compensation - noncontrolling interest


                 (19)


                 (17)

   Adjusted PBTA


$            7,765


$            6,622

 

 

Adjusted earnings per share:

 

Adjusted PBTA


$            7,765


$            6,622

Income tax expense


               (901)


               (878)

   Adjusted earnings


$            6,864


$            5,744

 





Diluted weighted average common shares


     47,321,818


     47,739,030

 





   Adjusted earnings per share


$            0.145


$            0.120

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR SFUFDUEDSESD